Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 200837
Defining mechanisms for pancreatic beta-cell dysfunction in type 2 diabetes
National Institutes of Health
Grant: 5P30DK116074-04
Stanford Diabetes Research Center
National Institutes of Health
Grant: 1UC4DK098085-01
The Human Islet Distribution Coordinating Center (UC4)
National Institutes of Health
Grant: 5R01DK108817-04
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans
National Institutes of Health
Grant: 5U01DK123743-04
Therapeutic targeting of human islets with recombinant regulatory T cells
National Institutes of Health
Grant: 5R01DK107507-04
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U
National Institutes of Health
Grant: 5UM1DK126185-05
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
NIDDK NIH HHS
Grant: R01 DK107507
NIDDK NIH HHS
Grant: R01 DK108817
NIDDK NIH HHS
Grant: UC4 DK098085
NIDDK NIH HHS
Grant: U24 DK098085
NIDDK NIH HHS
Grant: P30 DK020593
NIDDK NIH HHS
Grant: UM1 DK126185
NIDDK NIH HHS
Grant: U01 DK123743
NIDDK NIH HHS
Grant: P30 DK116074
Wellcome Trust
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals